No Data
$AKBA Stock Is up 8% Today. Here's What We See in Our Data.
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5
Express News | HC Wainwright & Co. Reiterates Buy on Akebia Therapeutics, Maintains $7.5 Price Target
Strategic Developments and Market Opportunities Drive Buy Rating for Akebia Therapeutics
Express News | Akebia Therapeutics: Ec Will Review Chmp Recommendation, Final Decision Expected in About Two Months
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Committee for Medicinal Products for Human Use, a committee of the European Medicines Agency (EMA) responsible for evaluating the quality, safety, and efficacy of human medicines for marketing authorization in the European Union.
74398752 : hold don't chase the market just wait for the dust to settle download stocktwits app and follow AKBA board. Good luck